• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Soligenix Inc - Articles and news items

Soligenix on IDR technology and SGX942

Blog / 10 May 2016 / Victoria White, Digital Content Producer

We discuss Innate Defense Regulator (IDR) technology with Soligenix’s Chief Scientific Officer, Dr Oreola Donini, and find out more about SGX942…

NIAID provides more funding to advance ricin vaccine RiVax

Industry news / 19 August 2015 / Victoria White

NIAID has provided Soligenix an additional $2.7 million in funding to advance the development of its heat stabilised ricin toxin vaccine, RiVax…

EC grants Orphan Drug Designation to SGX301

Industry news / 4 August 2015 / Victoria White

The EC has granted orphan drug designation to Solgenix’s synthetic hypericin (the active ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma…